Table 1.
Patient identifier | # of IgG clonotypes identified by MS | # of B-cell clonotypes identified by APD | Overlap | % of APD clonotypes confirmed by MS |
---|---|---|---|---|
PV1a | 22 | 4 | 0 | 0% |
PV8 | 37 | 12 | 3 | 25% |
PV16 | 30 | 11 | 0 | 0% |
PV3 | 34 | 3 | 0 | 0% |
PV3a | 56 | 6 | 1 | 17% |
PF1 | 18 | 4 | 3 | 75% |
PF1a | 23 | NA | NA | NA |
PF4 | 63 | NA | NA | NA |
PF4a | 55 | NA | NA | NA |
PF4b | 52 | NA | NA | NA |
MS: mass spectrometry; APD: antibody phage display
See also Tables S1, S2, S3